Chemours director granted 1,305 deferred stock units
MATHER COURTNEY reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
MATHER COURTNEY reported acquisition or exercise transactions in this Form 4 filing.
Chemours director Courtney Mather received a routine equity grant in the form of deferred stock units. On this Form 4, Mather was awarded 1,305 deferred stock units at an indicated value of $22.03 per unit, each equivalent to one share of Chemours common stock.
The deferred stock units, including associated dividend equivalent units, will become payable in the first month after Mather’s termination of service as a director. Following this grant, Mather holds a total of 7,552.3528 deferred stock units, representing deferred, not currently exercisable, equity-based compensation.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 1,305 | $22.03 | $29K |
Footnotes (2)
- F1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reportring Person's termination of service as a director.
- F2. Includes deferred stock units and dividend equivalent units.
Key Figures
Key Terms
Deferred Stock Units financial
dividend equivalent units financial
economic equivalent financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Chemours (CC) director Courtney Mather report in this Form 4?
Is Courtney Mather buying or selling Chemours (CC) stock in this filing?
When do Courtney Mather’s Chemours deferred stock units become payable?
How many Chemours deferred stock units does Courtney Mather hold after this grant?
What is the economic value per deferred stock unit in this Chemours Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.